BioTech/Drugs - South San Francisco, CA, US
UNITY is developing a new class of therapeutics to slow, halt or reverse diseases of aging. UNITY's current focus is on creating medicines to selectively eliminate or modulate senescent cells and thereby provide transformative benefit in age-related ophthalmologic and neurologic diseases. More information is available at www.unitybiotechnology.com.
Outlook
Drupal
Freshdesk
Microsoft Office 365
CloudFlare Hosting
Adobe Marketing Cloud